Llwytho...
Enzalutamide: targeting the androgen signalling pathway in metastatic castration‐resistant prostate cancer
Significant progress has been made in the understanding of the underlying cancer biology of castration‐resistant prostate cancer (CRPC) with the androgen receptor (AR) signalling pathway remaining implicated throughout the prostate cancer disease continuum. Reactivation of the AR signalling pathway...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | BJU Int |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4744713/ https://ncbi.nlm.nih.gov/pubmed/25818596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bju.13123 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|